Pharmaceutical compositions and methods for use

Details Pharmaceutical compositions and methods for use Pharmaceutical compositions and methods for use

1998-04-02

2000-12-26

Rotman, Alan L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

546300, 546303, C07D21363, C07D21365, A61K 3144

Patent

active

061660477

ABSTRACT:
Patients susceptible to or suffering from conditions and disorders, such as central nervous system disorders, are treated by administering to a patient in need thereof aryloxyalkylamines, including pyridyloxylalkylamines and phenoxyalkylamines, such as (3-(3-pyridyloxy)propyl)methylamine and (3-(5-bromo(3-pyridyloxy))propyl)methylamine.

REFERENCES:
patent: 4599336 (1986-07-01), Carson et al.
patent: 4927838 (1990-05-01), Guthrie et al.
patent: 5212188 (1993-05-01), Caldwell et al.
patent: 5585388 (1996-12-01), Cosford et al.
patent: 5597919 (1997-01-01), Dull et al.
patent: 5604231 (1997-02-01), Smith et al.
patent: 5616707 (1997-04-01), Crooks et al.
patent: 5616716 (1997-04-01), Dull et al.
patent: 5629325 (1997-05-01), Lin et al.
patent: 5663194 (1997-09-01), Mewshaw
patent: 5663356 (1997-09-01), Ruecroft et al.
patent: 5726316 (1998-03-01), Crooks et al.
patent: 5731314 (1998-03-01), Bencherif et al.
patent: 5811442 (1998-09-01), Bencherif et al.
patent: 5824692 (1998-10-01), Lippiello et al.
patent: 5861423 (1999-01-01), Caldwell et al.
Abreo, Melwyn A. et al., Novel 3-Pyridyl Ethers with Subnanomolar Affinity for Central Neuronal Nicotinic Acetylcholine Receptors, J. Med. Chem., 39, 817-825 (1996).
Bannon, A. W. et al., Broad-Sprectrum, Non-Opiod Analgesic Activity by Selective Modulation of Neuronal Nicotinic Acetylcholine Receptors, Science, vol. 29, 77-81, 1998.
Elliott, Richard L. et al., 2-(Aryloxymethyl) Azacyclic Analogues as Novel Nicotinic Acetylcholine Receptor (nAChR) Ligands, Bioorganic & Medicinal Chemistry Letters, vol. 6, 19, 2283-2288, (1996).
Elliott Richard L. et al., Novel 2-(2'-Furo (3,2-b) Pyridinyl) Pyrrolidines: Potent Neuronal Nicotinic Acetylcholine Receptor Ligands, Bioorganic & Medicinal Chemistry Letters, vol. 7, 21, pp. 2703-2708, 1997.
Holladay, Mark W. et al., Identification and Initial Structure-Activity Relationships of (R)-5-(2-Azetidinylmethoxy)-2-chloropy ridine (ABT-594), a Potent, Orally Active, Non-Opiate Analgesic Agent Acting via Neuronal Nicotinic Acetylcholine Receptors, J. Med. Chem., vol. 41, No. 4, pp. 407-412, 1998.
Holladay, Mark W. et al., Neuronal Nicotinic Acetylcholine Receptors as Targets for Drug Discovery, J. Med. Chem., vol. 40, No. 26, pp. 4169-4194, 1997.
Lin, Nan-Horng et al., Synthesis and Structure-Activity Relationships of Pyridine-Modified Analogs of 3-(2-((S)-Pyrrolidinyl Methoxy) Pyridine, A084543, A Potent Nicotinic Acetylcholine Receptor Agonist, Bioorganic & Medicinal Chemistry Letters, 8, pp. 249-254, 1998.
Lin, Nan-Horng et al., Structure-Activity Studies on 2-Methyl-3-(2(S)-pyrrolidinylmethoxy) pyrodine (ABT-089) : An Orally Bioavailable 3-Pyridyl Ether Nicotinic Acetylcholine Receptor Ligand with Cognition-Enchancing Properties, J. Med. Chem., vol. 40, pp. 385-390, 1997.
Bleicher, Leo et al., Synlett, pp. 1115-1116 (1995).
Lippiello, P. et al., JPET, vol. 279, No. 3, pp. 1422-1429 (1996).
Bencherif, M. et al., JPET, vol. 279, No. 3, pp. 1413-1421 (1996).
Tilley, J.W. et al., J. Med. Chem., vol. 30, pp. 185-193 (1987).
Guthrie, R. W. et al., J. Med. Chem., vol. 32, pp. 1820-1835 (1989).
Unangst, P.C. et al., J. Med. Chem., vol. 40, pp. 4026-4029 (1997).
Iwakura, Y. et al., Bulletin of the Chemical Society of Japan, vol 43, pp. 2531-2535 (1970).
Schaeffer, J. C. et al., J. of Pharm. Sciences, vol. 65(1), pp. 122-126 (1976).
Arora S. K. et al., J. Med. Chem., vol. 30, pp. 918-924 (1987).
Buschauer, A., Eur. J. Med. Chem., vol. 23, pp. 1-6 (1988).
Kawase, M. et al., Biochemical Pharmacology, vol. 31, No. 18, pp. 2983-2988 (1982).
Lever, Jr., O.W. et al., J. Med. Chem., vol. 28, pp. 1870-1874 (1985).
Pierson, M. E. et al., J. Med. Chem., vol. 32, pp. 859-863 (1989).
Ismaiel, A. M. et al., J. Med. Chem., vol. 40 (26), pp. 4415-4419 (1997).
Brenner J. B. et al., Aust. J. Chem., vol. 37, pp. 129-141 (1984).
Mitanl, K. et al., Chem. Pharm. Bull., vol. 36(10), pp. 4103-4120 (1988).
Mitanl, K. et al., Chem. Pharm. Bull., vol. 36(1), pp. 373-385 (1988).
Brenner, J. B. et al., Aust. J. Chem., vol. 37, pp. 129-141 (1984).
Wubbels, G. G. et al., J. Org. Chem., vol. 50, pp. 4499-4504 (1985).
Wubbels, G. G. et al., Tetrahedron Letters, vol. 30, No. 47, pp. 6477-6480 (1989).
Wubbels, G. G. et al., J. Org. Chem., vol. 60, pp. 2960-2961 (1995).
Mewshaw, R. E. et al., J. Medicinal Chem., vol. 40, No. 26, pp. 4235-4256 (1997).
Mutai, K. et al., Chemistry Letters, pp. 931-932 (1978).

Affiliated with

Also associated with

Rating

Pharmaceutical compositions and methods for use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical compositions and methods for use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions and methods for use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-995274